Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants | Zendy

Kathleen Winter | Zendy; James D. Cherry | Zendy; Kathleen Harriman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants

Author(s) -

Kathleen Winter,

James D. Cherry,

Kathleen Harriman

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw633

Subject(s) - medicine , diphtheria , tetanus , pediatrics , pregnancy , whooping cough , vaccination , neonatal intensive care unit , gestational age , retrospective cohort study , pertussis vaccine , immunization , immunology , antibody , genetics , biology

All US women are recommended to receive a tetanus, diphtheria, and acellular pertussis (Tdap) vaccine at 27-36 weeks gestation during each pregnancy to reduce the risk of pertussis to their infants. The impact of this strategy on severity of disease among infected infants has not been evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research